Trials / Completed
CompletedNCT07166887
Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male
Pharmacokinetics, Pharmacological Effects and Safety of Multi Dose of 7.5mg Tolvaptan Tablet in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Otsuka Beijing Research Institute · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
pharmacokinetics, pharmacological effects and safety of multi dose of 7.5mg Tolvaptan tablet in healthy male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tolvaptan | One dose on the first day and one dose on days 3-9, for a total of eight doses. |
Timeline
- Start date
- 2011-06-07
- Primary completion
- 2011-07-27
- Completion
- 2011-07-27
- First posted
- 2025-09-10
- Last updated
- 2025-09-10
Source: ClinicalTrials.gov record NCT07166887. Inclusion in this directory is not an endorsement.